The incidence of transient neurologic symptoms after spinal anesthesia with mepivacaine

Anesthesia and Analgesia

Volumn 101, Issue 3, 2005, Pages 661-665

  YaDeau, Jacques T ^a,b   Liguori, Gregory A ^a   Zayas, Victor M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEPIVACAINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGE; AGED; AMBULATORY SURGERY; ANKLE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; BACKACHE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EPIDURAL ANESTHESIA; FEMALE; FOLLOW UP; FOOT SURGERY; GENDER; HUMAN; KNEE ARTHROSCOPY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PATIENT POSITIONING; POSTDURAL PUNCTURE HEADACHE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SPINAL ANESTHESIA; TRANSIENT NEUROLOGIC SYMPTOM;

EID: 23944521996     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000167636.94707.d3     Document Type: Article

References (25)

1. Pollock JE. Transient neurologic symptoms: etiology, risk factors, and management. Reg Anesth Pain Med 2002;27:581-6.
2. Freedman JM, Li DK, Drasner K, et al. Transient neurologic symptoms after spinal anesthesia: an epidemiologic study of 1,863 patients. Anesthesiology 1998;89:633-41.
3. Liu SS, McDonald SB. Current issues in spinal anesthesia. Anesthesiology 2001;94:888-906.
4. Liguori GA, Zayas VM, Chisholm MF. Transient neurologic symptoms after spinal anesthesia with mepivacaine and lidocaine. Anesthesiology 1998;88:619-23.
5. Pawlowski J, Sukhani R, Pappas AL, et al. The anesthetic and recovery profile of two doses (60 and 80 mg) of plain mepivacaine for ambulatory spinal anesthesia. Anesth Analg 2000;91: 580-4.
6. Salazar F, Bogdanovich A, Adalia R, et al. Transient neurologic symptoms after spinal anaesthesia using isobaric 2% mepivacaine and isobaric 2% lidocaine. Acta Anaesthesiol Scand 2001; 45:240-5.
7. Zayas VM, Liguori GA, Chisholm MF, et al. Dose response relationships for isobaric spinal mepivacaine using the combined spinal epidural technique. Anesth Analg 1999;89:1167-71.
8. Salmela L, Aromaa U. Transient radicular irritation after spinal anesthesia induced with hyperbaric solutions of cerebrospinal fluid-diluted lidocaine 50 mg/ml or mepivacaine 40 mg/ml or bupivacaine 5 mg/ml. Acta Anaesthesiol Scand 1998;42:765-9.
9. Hiller A, Rosenberg PH. Transient neurological symptoms after spinal anaesthesia with 4% mepivacaine and 0.5% bupivacaine. Br J Anaesth 1997;79:301-5.
10. el-Shirbiny AM, Rasheed MH, Elmaghraby A, Motaweh M. Experiences with Carbocaine in spinal anaesthesia. Report of 20,000 cases. Acta Anaesthesiol Scand Suppl 1966;23:442-8.
11. Gaiser RR. Should intrathecal lidocaine be used in the 21st century? J Clin Anesth 2000;12:476-81.
12. Silvanto M, Tarkkila P, Makela ML, Rosenberg PH. The influence of ambulation time on the incidence of transient neurologic symptoms after lidocaine spinal anesthesia. Anesth Analg 2004; 98:642-6.
13. Turnbull DK, Shepherd DB. Post-dural puncture headache: pathogenesis, prevention and treatment. Br J Anaesth 2003;91: 718-29.
14. Rowlingson JC. To avoid "transient neurologic symptoms": the search continues. Reg Anesth Pain Med 2000;25:215-7.
15. Ho AM, Dion PW, Karmakar MK, Lee A. Estimating with confidence the risk of rare adverse events, including those with observed rates of zero. Reg Anesth Pain Med 2002;27:207-10.
16. Horlocker TT, McGregor DG, Matsushige DK, et al. A retrospective review of 4767 consecutive spinal anesthetics: central nervous system complications. Perioperative Outcomes Group. Anesth Analg 1997;84:578-84.
17. Aouad MT, Siddik SS, Jalbout MI, Baraka AS. Does pregnancy protect against intrathecal lidocaine-induced transient neurologic symptoms? Anesth Analg 2001;92:401-4.
18. Pollock JE, Neal JM, Stephenson CA, Wiley CE. Prospective study of the incidence of transient radicular irritation in patients undergoing spinal anesthesia. Anesthesiology 1996;84:1361-7.
19. Keld DB, Hein L, Dalgaard M, et al. The incidence of transient neurologic symptoms (TNS) after spinal anaesthesia in patients undergoing surgery in the supine position: hyperbaric lidocaine 5% versus hyperbaric bupivacaine 0.5%. Acta Anaesthesiol Scand 2000;44:285-90.
20. Kouri ME, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with lidocaine in volunteers. Anesth Analg 2004;98:75-80.
21. Hodgson PS, Liu SS, Batra MS, et al. Procaine compared with lidocaine for incidence of transient neurologic symptoms. Reg Anesth Pain Med 2000;25:218-22.
22. Ben-David B, Maryanovsky M, Gurevitch A, et al. A comparison of minidose lidocaine-fentanyl and conventional-dose lidocaine spinal anesthesia. Anesth Analg 2000;91:865-70.
23. Tong D, Wong J, Chung F, et al. Prospective study on incidence and functional impact of transient neurologic symptoms associated with 1% versus 5% hyperbaric lidocaine in short urologic procedures. Anesthesiology 2003;98:485-94.
24. Hiller A, Karjalainen K, Balk M, Rosenberg PH. Transient neurological symptoms after spinal anaesthesia with hyperbaric 5% lidocaine or general anaesthesia. Br J Anaesth 1999;82:575-9.
25. Carey TS, Boden SD. A critical guide to case series reports. Spine 2003;28:1631-4.